Global Information
회사소개 | 문의 | 위시리스트

중동 11개국의 자동 미생물 검사 시장 분석 : 공급업체 전략, 검사 건수 및 매출 예측

Middle East Automated Microbiology Market, 2019-2023:An 11-Country Analysis-Supplier Strategies, Volume & Sales Forecasts for 100 Molecular Diagnostic, Microbial Identification, Susceptibility, Blood Culture, Urine Screening & Immunodiagnostic Tests

리서치사 Venture Planning Group
발행일 상품 코드 509953
페이지 정보 영문 500 Pages
가격
US $ 8,250 ₩ 10,112,000 DataPack (Local License)
US $ 9,850 ₩ 12,073,000 PDF by E-mail (Local License)
US $ 15,700 ₩ 19,243,000 PDF by E-mail (Global License)


중동 11개국의 자동 미생물 검사 시장 분석 : 공급업체 전략, 검사 건수 및 매출 예측 Middle East Automated Microbiology Market, 2019-2023:An 11-Country Analysis-Supplier Strategies, Volume & Sales Forecasts for 100 Molecular Diagnostic, Microbial Identification, Susceptibility, Blood Culture, Urine Screening & Immunodiagnostic Tests
발행일 : 페이지 정보 : 영문 500 Pages

중동 11개국의 자동 미생물 검사(Automated Microbiology) 시장에 대해 조사 분석했으며, 현재 공급업체와 잠재적인 시장 진출 기업의 향후 5년간 성장 기회에 초점을 맞추어 국가별 분석, 기준 표본, 적용, 주요 시스템, 기술, 경쟁 평가 등의 정보를 전해드립니다.

제1장 서론

제2장 자동 미생물 검사 시장의 비지니스 환경

제3장 신제품 개발 기회

제4장 분산형 검사 제품의 설계 기준

제5장 대체적인 시장 보급 전략

제6장 잠재적인 시장 진출 장벽과 위험

제7장 시장과 기술 개요

  • 서론
  • 주요 기준 표본
    • 소변
    • 무균액
    • 인후 면봉, 호흡기 분비물
    • 생식기 분비물
    • 농양/창상
    • 타액
  • 검사 적용
    • 미생물 동정
    • 항생물질 감수성
    • 소변 스크리닝
    • 혈액 배양
  • 주요 자동/반자동 미생물 검사 시스템
    • 일반 미생물 검사 시스템
    • 특수 미생물 검사 시스템
    • 분자 진단 시스템
    • 면역 진단 시스템
  • 새로운 진단 기술
    • 분자 진단
    • 단일클론항체
    • 면역측정법(Immunoassays)
    • 차분 광산란(Differential Light Scattering)
    • IT
    • AI(인공지능)
    • 리포솜
    • 유세포분석기(Flow Cytometry)
    • 크로마토그래피
    • 영상 진단
    • 겔 미세액적(Gel Microdroplets)
    • 기타

제8장 국가별 분석 : 매출과 건수 예측(분자 진단, 미생물 동정, 항생물질 감수성, 혈액 배양, 소변 스크리닝, 면역 진단 검사 등), 공급업체 점유율

  • 바레인
  • 이란
  • 이라크
  • 이스라엘
  • 요르단
  • 쿠웨이트
  • 레바논
  • 오만
  • 카타르
  • 사우디아라비아
  • 아랍에미리트(UAE)

제9장 경쟁 평가

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio Inc.
  • Tecan
  • Wallac/PE
  • Wako
KSM 17.06.20

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 11-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification  Antibiotic Susceptibility  Urine Screening  Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains over 500 pages and 54 tables

Table of Contents

I. Introduction

II. Automated Microbiology Market Business Environment

III. New Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Market and Technology Overview

  • A. Introduction
    • 1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
    • 2. Traditional Practices
    • 3. Technological Challenges
    • 4. Automation: Impact on the Microbiology Laboratory and the Patient
  • B. Major Specimen Types
    • 1. Urine
    • 2. Sterile Fluids: Blood, Serum, and CSF
    • 3. Throat Swabs and Respiratory Secretions
    • 4. Genital Secretions
    • 5. Stool
    • 6. Abscess/Wound
    • 7. Sputum
    • 8. Saliva
  • C. Test Applications
    • 1. Microbial Identification
    • 2. Antibiotic Susceptibility
    • 3. Urine Screening
      • a. Photometry
      • b. Bioluminescence
      • c. Colorimetric Filtration
      • d. Enzymatic Detection
      • e. Optical Detection
    • 4. Blood Cultures
  • D. Major Automated and Semi-automated Microbiology Systems
    • 1. Multiple Purpose Microbiology Systems
    • 2. Specialized Microbiology Systems
    • 3. Molecular Diagnostic Systems
    • 4. Immunodiagnostic Systems
  • E. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
      • a. DNA Sequencing
      • b. DNA and RNA Probe Technologies
      • c. Detection Technologies
      • d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VIII. Country Analyses: Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests, Supplier Shares

  • Bahrain
  • Iran
  • Iraq
  • Israel
  • Jordan
  • Kuwait
  • Lebanon
  • Oman
  • Qatar
  • Saudi Arabia
  • United Arab Emirates

IX. Competitive Assessments

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan
  • Wallac/PE
  • Wako

List of Tables

  • Bahrain
  • Microbiology Specimen Volume Forecast by Type
  • Bahrain
  • Microbiology Test Volume Forecasts by Application
  • Bahrain
  • Microbiology Consumables Market Forecast by Application
  • Bahrain
  • Infectious Disease Test Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Diagnostics Market Forecast by Test
  • Bahrain
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iran
  • Microbiology Specimen Volume Forecast by Type
  • Iran
  • Microbiology Test Volume Forecasts by Application
  • Iran
  • Microbiology Consumables Market Forecast by Application
  • Iran
  • Infectious Disease Test Volume Forecast by Assay
  • Iran
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iran
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iran
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iraq
  • Microbiology Specimen Volume Forecast by Type
  • Iraq
  • Microbiology Test Volume Forecasts by Application
  • Iraq
  • Microbiology Consumables Market Forecast by Application
  • Iraq
  • Infectious Disease Test Volume Forecast by Assay
  • Iraq
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iraq
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iraq
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Israel
  • Microbiology Specimen Volume Forecast by Type
  • Israel
  • Microbiology Test Volume Forecasts by Application
  • Israel
  • Microbiology Consumables Market Forecast by Application
  • Israel
  • Infectious Disease Test Volume Forecast by Assay
  • Israel
  • Infectious Disease Diagnostics Market Forecast by Test
  • Israel
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Israel
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Jordan
  • Microbiology Specimen Volume Forecast by Type
  • Jordan
  • Microbiology Test Volume Forecasts by Application
  • Jordan
  • Microbiology Consumables Market Forecast by Application
  • Jordan
  • Infectious Disease Test Volume Forecast by Assay
  • Jordan
  • Infectious Disease Diagnostics Market Forecast by Test
  • Jordan
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Jordan
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Kuwait
  • Microbiology Specimen Volume Forecast by Type
  • Kuwait
  • Microbiology Test Volume Forecasts by Application
  • Kuwait
  • Microbiology Consumables Market Forecast by Application
  • Kuwait
  • Infectious Disease Test Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Diagnostics Market Forecast by Test
  • Kuwait
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Lebanon
  • Microbiology Specimen Volume Forecast by Type
  • Lebanon
  • Microbiology Test Volume Forecasts by Application
  • Lebanon
  • Microbiology Consumables Market Forecast by Application
  • Lebanon
  • Infectious Disease Test Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Diagnostics Market Forecast by Test
  • Lebanon
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Oman
  • Microbiology Specimen Volume Forecast by Type
  • Oman
  • Microbiology Test Volume Forecasts by Application
  • Oman
  • Microbiology Consumables Market Forecast by Application
  • Oman
  • Infectious Disease Test Volume Forecast by Assay
  • Oman
  • Infectious Disease Diagnostics Market Forecast by Test
  • Oman
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Oman
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Qatar
  • Microbiology Specimen Volume Forecast by Type
  • Qatar
  • Microbiology Test Volume Forecasts by Application
  • Qatar
  • Microbiology Consumables Market Forecast by Application
  • Qatar
  • Infectious Disease Test Volume Forecast by Assay
  • Qatar
  • Infectious Disease Diagnostics Market Forecast by Test
  • Qatar
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Qatar
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Saudi Arabia
  • Microbiology Specimen Volume Forecast by Type
  • Saudi Arabia
  • Microbiology Test Volume Forecasts by Application
  • Saudi Arabia
  • Microbiology Consumables Market Forecast by Application
  • Saudi Arabia
  • Infectious Disease Test Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Diagnostics Market Forecast by Test
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • United Arab Emirates
  • Microbiology Specimen Volume Forecast by Type
  • United Arab Emirates
  • Microbiology Test Volume Forecasts by Application
  • United Arab Emirates
  • Microbiology Consumables Market Forecast by Application
  • United Arab Emirates
  • Infectious Disease Test Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Diagnostics Market Forecast by Test
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top
전화 문의
F A Q